Advanced in Olfactory Neuroblastoma

Jiade J. Lu

4365 Kangxin Road, 
Shanghai, CN 
Advanced in Olfactory Neuroblastoma
4365 Kangxin Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jiade Lu practices in Shanghai, China. Lu is rated as an Advanced expert by MediFind in the treatment of Olfactory Neuroblastoma. Their top areas of expertise are Nasopharyngeal Carcinoma, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Sinus Cancer.

Their clinical research consists of co-authoring 110 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Olfactory Neuroblastoma.

Locations

4365 Kangxin Road, Shanghai, 201315, China
Other Locations
4365 Kangxin Road, Shanghai, 200321, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I/II Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
Phase I/II Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
Enrollment Status: Terminated
Publish Date: February 17, 2020
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
Phase Ⅲ Study of Neoadjuvant TPF Chemotherapy Followed by Radiotherapy With Concurrent Nimotuzumab or Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma (NPC).
Phase Ⅲ Study of Neoadjuvant TPF Chemotherapy Followed by Radiotherapy With Concurrent Nimotuzumab or Cisplatin for Locoregionally Advanced Nasopharyngeal Carcinoma (NPC).
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Radiation, Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

110 Total Publications

Autophagy-dependent sensitization effects of PARP inhibitors on recurrent nasopharyngeal carcinoma treated with carbon ion and photon irradiation.
Autophagy-dependent sensitization effects of PARP inhibitors on recurrent nasopharyngeal carcinoma treated with carbon ion and photon irradiation.
Journal: Acta biochimica et biophysica Sinica
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile